These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1599 related items for PubMed ID: 11377686

  • 1. Diagnostic criteria and classification of mastocytosis: a consensus proposal.
    Valent P, Horny HP, Escribano L, Longley BJ, Li CY, Schwartz LB, Marone G, Nuñez R, Akin C, Sotlar K, Sperr WR, Wolff K, Brunning RD, Parwaresch RM, Austen KF, Lennert K, Metcalfe DD, Vardiman JW, Bennett JM.
    Leuk Res; 2001 Jul; 25(7):603-25. PubMed ID: 11377686
    [Abstract] [Full Text] [Related]

  • 2. Mastocytosis: state of the art.
    Horny HP, Sotlar K, Valent P.
    Pathobiology; 2007 Jul; 74(2):121-32. PubMed ID: 17587883
    [Abstract] [Full Text] [Related]

  • 3. Myelomastocytic overlap syndromes: biology, criteria, and relationship to mastocytosis.
    Valent P, Sperr WR, Samorapoompichit P, Geissler K, Lechner K, Horny HP, Bennett JM.
    Leuk Res; 2001 Jul; 25(7):595-602. PubMed ID: 11377685
    [Abstract] [Full Text] [Related]

  • 4. Systemic mastocytosis in adults: 2012 Update on diagnosis, risk stratification, and management.
    Pardanani A.
    Am J Hematol; 2012 Apr; 87(4):401-11. PubMed ID: 22410759
    [Abstract] [Full Text] [Related]

  • 5. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.
    Noack F, Escribano L, Sotlar K, Nunez R, Schuetze K, Valent P, Horny HP.
    Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351
    [Abstract] [Full Text] [Related]

  • 6. Update on Mastocytosis (Part 2): Categories, Prognosis, and Treatment.
    Azaña JM, Torrelo A, Matito A.
    Actas Dermosifiliogr; 2016 Feb; 107(1):15-22. PubMed ID: 26525106
    [Abstract] [Full Text] [Related]

  • 7. Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis.
    Sperr WR, Escribano L, Jordan JH, Schernthaner GH, Kundi M, Horny HP, Valent P.
    Leuk Res; 2001 Jul; 25(7):529-36. PubMed ID: 11377677
    [Abstract] [Full Text] [Related]

  • 8. A case of 'smouldering' mastocytosis with high mast cell burden, monoclonal myeloid cells, and C-KIT mutation Asp-816-Val.
    Jordan JH, Fritsche-Polanz R, Sperr WR, Mitterbauer G, Födinger M, Schernthaner GH, Christian Bankl H, Gebhart W, Chott A, Lechner K, Valent P.
    Leuk Res; 2001 Jul; 25(7):627-34. PubMed ID: 11377687
    [Abstract] [Full Text] [Related]

  • 9. Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms.
    Valent P, Sperr WR, Schwartz LB, Horny HP.
    J Allergy Clin Immunol; 2004 Jul; 114(1):3-11; quiz 12. PubMed ID: 15241337
    [Abstract] [Full Text] [Related]

  • 10. Diagnosis of mastocytosis: general histopathological aspects, morphological criteria, and immunohistochemical findings.
    Horny HP, Valent P.
    Leuk Res; 2001 Jul; 25(7):543-51. PubMed ID: 11377679
    [Abstract] [Full Text] [Related]

  • 11. Utility of flow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosis.
    Escribano L, Díaz-Agustín B, Bellas C, Navalón R, Nuñez R, Sperr WR, Schernthaner GH, Valent P, Orfao A.
    Leuk Res; 2001 Jul; 25(7):563-70. PubMed ID: 11377681
    [Abstract] [Full Text] [Related]

  • 12. Systemic mastocytosis in adults: 2013 update on diagnosis, risk stratification, and management.
    Pardanani A.
    Am J Hematol; 2013 Jul; 88(7):612-24. PubMed ID: 23720340
    [Abstract] [Full Text] [Related]

  • 13. Diagnosis and management of mastocytosis: an emerging challenge in applied hematology.
    Valent P.
    Hematology Am Soc Hematol Educ Program; 2015 Jul; 2015():98-105. PubMed ID: 26637707
    [Abstract] [Full Text] [Related]

  • 14. Systemic mastocytosis in adults: 2015 update on diagnosis, risk stratification, and management.
    Pardanani A.
    Am J Hematol; 2015 Mar; 90(3):250-62. PubMed ID: 25688753
    [Abstract] [Full Text] [Related]

  • 15. Biology, classification and treatment of human mastocytosis.
    Valent P.
    Wien Klin Wochenschr; 1996 Mar; 108(13):385-97. PubMed ID: 8766423
    [Abstract] [Full Text] [Related]

  • 16. [Mastocytosis, classification, biological diagnosis and therapy].
    Arock M.
    Ann Biol Clin (Paris); 2004 Mar; 62(6):657-69. PubMed ID: 15563424
    [Abstract] [Full Text] [Related]

  • 17. Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal.
    Valent P, Sotlar K, Sperr WR, Escribano L, Yavuz S, Reiter A, George TI, Kluin-Nelemans HC, Hermine O, Butterfield JH, Hägglund H, Ustun C, Hornick JL, Triggiani M, Radia D, Akin C, Hartmann K, Gotlib J, Schwartz LB, Verstovsek S, Orfao A, Metcalfe DD, Arock M, Horny HP.
    Ann Oncol; 2014 Sep; 25(9):1691-1700. PubMed ID: 24675021
    [Abstract] [Full Text] [Related]

  • 18. Systemic mastocytosis in adults: 2021 Update on diagnosis, risk stratification and management.
    Pardanani A.
    Am J Hematol; 2021 Apr 01; 96(4):508-525. PubMed ID: 33524167
    [Abstract] [Full Text] [Related]

  • 19. Mastocytosis: from a Molecular Point of View.
    Komi DEA, Rambasek T, Wöhrl S.
    Clin Rev Allergy Immunol; 2018 Jun 01; 54(3):397-411. PubMed ID: 28725969
    [Abstract] [Full Text] [Related]

  • 20. Systemic mastocytosis in adults: 2011 update on diagnosis, risk stratification, and management.
    Pardanani A.
    Am J Hematol; 2011 Apr 01; 86(4):362-71. PubMed ID: 21442641
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 80.